Skip directly to searchSkip directly to the site navigationSkip directly to the page's main content

Health Highlight Report for McKinley County

Invasive Pneumococcal Disease - Persons Aged 65 Years and Older: Cases per 100,000 Population, 2012-2016

  • McKinley County
    120.4
    95% Confidence Interval (86 - 154.9)
    Statistical StabilityStable
    New Mexico
    33.2
    U.S.
    25
  • McKinley County Compared to State

    gauge ranking
    Description of Dashboard Gauge

    Description of the Dashboard Gauge

    This "dashboard" type graphic is based on the community data on the right. It compares the community value on this indicator to the state overall value.
    • Excellent = The community's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The community's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The community's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The community's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The community value is considered statistically significantly different from the state value if the state value is outside the range of the community's 95% confidence interval. If the community's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the community's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the community and state values. When selecting priority health issues to work on, a community should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the community number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

''Streptococcus pneumoniae'' (pneumococcus) remains a leading infectious cause of serious illness, including bacteremia, meningitis, and pneumonia, among older adults in the United States. Use of a 7-valent pneumococcal conjugate vaccine (PCV7) since 2000 and PCV13 since 2010 among children in the United States has reduced pneumococcal infections directly and indirectly among children, and indirectly among adults. By 2013, the incidence of invasive pneumococcal disease (IPD) caused by serotypes unique to PCV13 among adults aged 65 years and older had declined by approximately 50% compared with 2010, when PCV13 replaced PCV7 in the pediatric immunization schedule. However, in 2013 an estimated 13,500 cases of IPD occurred among adults aged 65 years and older. Approximately, 20% to 25% of IPD cases and 10% of community-acquired pneumonia cases in adults aged 65 years and older are caused by PCV13 serotypes and are potentially preventable with the use of PCV13 in this population. Additionally, New Mexico consistently has higher rates of IPD among adults aged 65 years and older when compared to national rates. The greatest burden of disease is seen in the American Indians/Alaska Natives (AIAN). The rate of disease among AIAN adults aged 65 years and older in 2013 was 137.6 per 100,000 compared to 34.1 per 100,000 among non- AIAN adults aged 65 years and older.

How Are We Doing?

Rates of IPD have decreased across all ages, including those adults aged 65 years and older, since the introduction of PCV7 in children in 2000 and PCV13 in 2010.

What Is Being Done?

On August 13, 2014, the Advisory Committee on Immunization Practices (ACIP) recommended routine use of 13-valent pneumococcal conjugate vaccine (PCV13 [Prevnar 13, Wyeth Pharmaceuticals, Inc., a subsidiary of Pfizer Inc.]) among adults aged 65 years and older. PCV13 should be administered in series with the 23-valent pneumococcal polysaccharide vaccine (PPSV23 [Pneumovax23, Merck & Co., Inc.]), the vaccine currently recommended for adults aged 65 years and older. Additionally, New Mexico is one of ten national sites that participates in the Centers for Disease Control and Prevention (CDC) Emerging Infectious Programs (EIP), Active Bacterial Core Surveillance (ABCs) which includes conducting active population-based surveillance for invasive ''Streptococcus pneumoniae''. Also, as a part of the CDC EIP ABCs network, New Mexico is participating in a study evaluating the effectiveness of PCV13 in adults aged 65 years and older.

Healthy People Objective IID-4.2:

New invasive pneumococcal infections among adults aged 65 years and older
U.S. Target: 31 new cases per 100,000 adults aged 65 years and older

Data Sources

New Mexico Data Source, 2006 and later: New Mexico Electronic Disease Surveillance System (NM-EDSS), Infectious Disease Epidemiology Bureau, New Mexico Department of Health.   Population Estimates: University of New Mexico, Geospatial and Population Studies (GPS) Program, http://gps.unm.edu/.  

Measure Description for Invasive Pneumococcal Disease - Persons Aged 65 Years and Older

Definition: Rate per 100,000 of invasive pneumococcal disease in adults aged 65 years and older in New Mexico. Number of ''Streptococcus pneumoniae'' in New Mexico adults aged 65 years and older divided by the population of New Mexico residents adults aged 65 years and older x 100,000.
Numerator: The number of invasive, culture-confirmed cases of ''Streptococcus pneumoniae'' in adults aged 65 years and older in New Mexico in one calendar year time.
Denominator: Population of New Mexico resident adults aged 65 years and older in one calendar year time period.

Indicator Profile Report

Invasive Pneumococcal Disease - Persons Aged 65 Years and Older (exits this report)

Date Content Last Updated

08/25/2017
The information provided above is from the New Mexico Department of Health's NM-IBIS web site (http://ibis.health.state.nm.us). The information published on this website may be reproduced without permission. Please use the following citation: "Retrieved Fri, 20 September 2019 from New Mexico Department of Health, Indicator-Based Information System for Public Health Web site: http://ibis.health.state.nm.us".

Content updated: Fri, 21 Jun 2019 11:52:53 MDT